Cytokine production by human peripheral blood mononuclear cells stimulated by a Pseudomonas aeruginosa culture filtrate: Role of plasma and polymyxin B

International Journal of Artificial Organs

Volumn 19, Issue 5, 1996, Pages 276-283

  Sundaram, S ^a   Barrett, T W ^a   Butt, N K ^a   Porat, R ^a   King, A J ^a   Pereira, B J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Bacterial contamination; Cytokine production; Endotoxin; Hemodialysis

Indexed keywords

BACTERIA; HEMODIALYZERS; PLASMA (HUMAN); SULFUR COMPOUNDS;

BACTERIAL CONTAMINATION; CULTURE FILTRATE; CYTOKINE PRODUCTION; ENDOTOXIN; HAEMODIALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELLS; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; SULPHATES; TRANSMEMBRANES;

DIALYSIS;

CYTOKINE; ENDOTOXIN; POLYMYXIN B;

ARTICLE; CELL CULTURE; HEMODIALYSIS; MONONUCLEAR CELL; PLASMA; PSEUDOMONAS AERUGINOSA;

EID: 0030068031     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900504     Document Type: Article

References (32)

1. Mahiout A, Shaldon S, Lonnemann G, Koch KM. Standardized pyrogen solution for dialyzer permeability testing. Blood Purif 1992; 10 (2): 76-7.
2. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated diseases in the United States. ASAIO Journal 1990; 39: 71-80.
3. Baurmeister U, Vienken J, Daum V. High-flux dialysis membranes: endotoxin transfer by backfiltration can be a problem. Nephrol Dial Transplant 1989; 4 (Suppl 3): 89-93.
4. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-62.
5. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA. Detection of endotoxin-like interleukin-1 inducing activity during in vitro dialysis. Kidney Int 1988; 33; 29-35.
6. Lonnemann G, Behme TC, Lenzner B et al. Permeability of dialyzer membranes of TNF-α-inducing substances derived from water bacteria. Kidney Int 1993; 42: 61-8.
7. Evans RC, Holmes CJ. In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif 1991; 9: 92-101.
8. Bingel M, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Human interleukin-1 production during hemodialysis. Nephron 1986; 43: 161-3.
9. Pereira BJG, Snodgrass B, King AJ, Hogan P. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 1995; 47: 603-10.
10. Port FK, Bernick JJ. Pyrogen and endotoxin reactions during hemodialysis. Contrib Nephrol 1983; 36: 100-6.
11. Bommer J, Becker K, Urbascheck R, Ritz E, Urbascheck B. No evidence for endotoxin transfer across high flux polysulfone membranes. Clin Nephrol 1987; 27: 278-82.
12. Lonnemann G. The role of contaminated dialysate in hemodialysis-associated cytokine production. Contrib Nephrol 1990; 86: 121-7.
13. Harding GB, Klein E, Pass T, Wright R, Million C. Endotoxin and bacterial contamination of dialysis center water and dialysate: a cross-sectional survey. Int J Artif Organs 1990; 13 :39-43.
14. Tobias PS, Soldau K, Ulevitch RJ. Identification of a lipid A binding site in the acute phase-reactant lipopolysaccharide binding protein. J Biol Chem 1989; 264: 10867-71.
15. Mathison JC, Wolfson E, Steinemann S, Tobias PS, Ulevitch RJ. Lipopolysaccharide (LPS) recognition in macrophage. Participation of LPS-bindmg protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J Clin Invest Med 1993; 92: 2053-9.
16. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992; 6: 532-7.
17. Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW. Bactericidal/permeability increasing protein has endotoxin-neutralizing activity. J Immunol 1990; 144: 662-6.
18. Schumann RR, Leong SR, Flagg GW, et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-31.
19. Lonnemann G, Mahiout A, Schindler R, Colton CK. Pyrogen retention by the polyamide membranes. In: Shaldon S. Koch KM, eds. Contrib Nephrol: Polyamide-the evolution of a synthetic membrane for renal therapy. 1992; 96: 47-63.
20. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78: 1275-81.
21. Lonnemann G, Endres S, van der Meer JW, Cannon JC, Dinarello CA. A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. Lymphokine Res 1988; 7: 75-84.
22. Porat R, Poutsiaka DD, Miller LC, Granowitz EV, Dinarello CA. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB Journal 1992; 6: 2482-6.
23. Opal SM, Palardy JE, Marra MN, Fisher Jr JR. McKellingon BM, Scott RW. Relative concentrations of endotoxin-bindings proteins in body fluids during infection. Lancet 1994; 344: 429-31.
24. Cooperstock MS. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemotherap 1974; 6: 422-5.
25. Buret A, Cripps AW. The immunoevasive activities of Pseudomonas aeruginosa: Relevance for cystic fibrosis. Am Rev Respir Dis 1993; 148: 793-805.
26. Misfeldt ML, Leggard PK, Howell SE, Fornella MH, LeGrand RD. Induction of interleukin-1 from murine peritoneal macrophages by Pseudomonas aeruginosa exotoxin A. Infect Immun 1990; 58: 978-82.
27. Chen YHU, Hancock REW, Mishell RI. Mitogenic effects of purified outer membrane proteins from Pseudomonas aeruginosa. Infect Immun 1980; 28: 178-84.
28. Staugas RE, Harvey DP, Ferrante A, Nandoskar M, Allison AC. Induction of tumor necrosis factor (TNF) and interfeukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma Interferon and IL-1 production in human leukocytes. Infect Immun 1992; 60: 3162-8.
29. Ulmer AJ, Pryjma J, Tamok Z, Ernst M, Rad HD. Inhibiting and stimulatory effects of PS. aeruginosa pyocyanin in human T and B lymphocytes and human monocytes. Infect Immun 1990; 58: 808-15.
30. Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 1990; 85: 1694-7.
31. Fischer E, Marano MA, Barber AE. Comparison between effects of interleukin-1 a administration and sublethal endotoxemia in primates. Am J Physiol 1991; 261: R442-52.
32. Massion PP, Inoue H, Richman-Eisenstat H, et al. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994; s93: 26-32.